US Patent Issued to AstraZeneca on Aug. 4 for "Inhibitors of myeloperoxidase" (Swedish Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,282, issued on Aug. 4, was assigned to AstraZeneca AB (Sodertalje, Sweden).

"Inhibitors of myeloperoxidase" was invented by Tord Inghardt (Sodertalje, Sweden), Eva-Lotte Lindstedt (Sodertalje, Sweden), Ulrik Jurva (Sodertalje, Sweden) and Nidhal Selmi (Sodertalje, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The specification generally relates to compounds of Formula (I), (Ia), and (Ib): and pharmaceutically acceptable salts thereof, where X, Y1, Y2, Y3, Y4, and Y5 and X1, X2, r, and q, have any of the meanings defined herein, together with compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme MPO,...